JPMorgan Chase & Co. Acquires 73,350 Shares of Quipt Home Medical Corp. (NASDAQ:QIPT)

JPMorgan Chase & Co. lifted its stake in Quipt Home Medical Corp. (NASDAQ:QIPTFree Report) by 241.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,753 shares of the company’s stock after purchasing an additional 73,350 shares during the period. JPMorgan Chase & Co. owned 0.24% of Quipt Home Medical worth $316,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Kanen Wealth Management LLC bought a new stake in Quipt Home Medical during the fourth quarter valued at about $4,346,000. Jane Street Group LLC grew its stake in shares of Quipt Home Medical by 28.5% during the 3rd quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock valued at $122,000 after acquiring an additional 9,290 shares during the period. Barclays PLC increased its holdings in Quipt Home Medical by 79.2% in the 3rd quarter. Barclays PLC now owns 87,425 shares of the company’s stock worth $256,000 after acquiring an additional 38,635 shares in the last quarter. Royce & Associates LP raised its stake in Quipt Home Medical by 12.1% during the 4th quarter. Royce & Associates LP now owns 1,982,089 shares of the company’s stock worth $6,045,000 after acquiring an additional 213,300 shares during the period. Finally, Raymond James Financial Inc. purchased a new position in Quipt Home Medical during the fourth quarter valued at approximately $113,000. 42.85% of the stock is owned by institutional investors.

Quipt Home Medical Stock Performance

Shares of NASDAQ QIPT opened at $2.17 on Friday. The stock has a market cap of $93.51 million, a PE ratio of -12.76 and a beta of 0.65. Quipt Home Medical Corp. has a 1 year low of $1.86 and a 1 year high of $4.17. The firm has a fifty day moving average price of $2.25 and a 200-day moving average price of $2.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.22 and a quick ratio of 0.87.

Quipt Home Medical (NASDAQ:QIPTGet Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter. Quipt Home Medical had a negative net margin of 2.90% and a negative return on equity of 6.70%. Equities analysts anticipate that Quipt Home Medical Corp. will post -0.05 earnings per share for the current fiscal year.

Quipt Home Medical Company Profile

(Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

Further Reading

Institutional Ownership by Quarter for Quipt Home Medical (NASDAQ:QIPT)

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.